Mayo AF‐Specific Symptom Inventory
shortness of breath
The mean adjusted difference in MAFSI frequency score at 12 months between women randomized to ablation versus drug therapy was −2.5 (95% CI, −3.4 to −1.6) (Table Of the 4 most common AF symptoms reported in MAFSI by women, the magnitude of symptom improvement as reflected in the percent of patients achieving never or rare symptom frequency at 12 months with ablation relative to drug therapy was largest for tired/lack of energy, inability to exercise, and palpitations/heart fluttering/racing but not shortness of breath (Table 